Literature DB >> 19640570

Risk of deep venous thrombosis (DVT) in bedridden or wheelchair-bound multiple sclerosis patients: a prospective study.

G Arpaia1, P M Bavera, D Caputo, L Mendozzi, R Cavarretta, G B Agus, M Milani, E Ippolito, C Cimminiello.   

Abstract

BACKGROUND: Multiple sclerosis (MS) often causes progressive loss of mobility, leading to limb paralysis. Venous and lymphatic stasis is a risk condition for venous thromboembolism (VTE). There is, however, no data on the frequency of VTE complicating the progression of MS. The aim of this study was to assess the frequency of deep vein thrombosis (DVT) in patients with late-stage MS attending a neurology center for rehabilitation. PATIENTS AND METHODS: A total of 132 patients with MS were enrolled, 87 women and 45 men, mean age 58+/-11 years. The disease had started on average 18.7 years before; patients reported 9.6 hours bedridden per day or 14.3 hours wheelchair-bound. Only 25 patients reported a residual ability to walk alone or with help. Lower limb edema was present in 113 patients, bilateral in 41 cases. At admission all patients underwent extended compression ultrasonography. Their plasma D-dimer levels were measured. No antithrombotic prophylaxis was given.
RESULTS: DVT was found in 58 patients (43.9%); 32 had a history of VTE. Forty of these patients (69%) had chronic lower limb edema, in 19 cases bilateral. D-dimer levels in the DVT patients were significantly higher than in patients without DVT (553+/-678 vs. 261+/-152 ng/mL, p=0.0112, Mann-Whitney Test). Nearly half the DVT patients (26, 45%) had high D-dimer levels (701+/-684 ng/mL). Of the 74 patients without DVT, 48 had normal D-dimer (193.37+/-67.28 ng/mL) and 26 high (387.61+/-187.42 ng/mL).
CONCLUSIONS: The frequency of DVT in late-stage MS may be over 40%. The long history of the disease means the onset of each episode cannot be established with certainty. A number of patients with positive CUS findings had negative D-dimer values, suggesting a VTE event in the past. However, the level of DVT risk in this series should lead physicians to consider the systematic application of long-term preventive measures. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19640570     DOI: 10.1016/j.thromres.2009.06.023

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  11 in total

1.  Microengineered Human Vein-Chip Recreates Venous Valve Architecture and Its Contribution to Thrombosis.

Authors:  Navaneeth Krishna Rajeeva Pandian; Brandon K Walther; Rishi Suresh; John P Cooke; Abhishek Jain
Journal:  Small       Date:  2020-11-17       Impact factor: 13.281

2.  Anesthetic management of the emergency laparotomy for a patient with multiple sclerosis -A case report-.

Authors:  Ki Hwa Lee; Jang Su Park; Sang Il Lee; Ji Yeon Kim; Kyeong Tae Kim; Won Ju Choi; Jeong Won Kim
Journal:  Korean J Anesthesiol       Date:  2010-11-25

3.  Risk of venous thromboembolism in patients nursed at home or in long-term care residential facilities.

Authors:  Guido Arpaia; Federico Ambrogi; Maristella Penza; Aladar Bruno Ianes; Alessandra Serras; Patrizia Boracchi; Claudio Cimminiello
Journal:  Int J Vasc Med       Date:  2011-06-13

Review 4.  Aspirin and multiple sclerosis.

Authors:  Sheila Tsau; Mitchell R Emerson; Sharon G Lynch; Steven M LeVine
Journal:  BMC Med       Date:  2015-06-29       Impact factor: 8.775

5.  Short Physical Performance Battery for cardiovascular disease inpatients: implications for critical factors and sarcopenia.

Authors:  Tomohiro Yasuda; Toshiaki Nakajima; Tatsuya Sawaguchi; Naohiro Nozawa; Tomoe Arakawa; Reiko Takahashi; Yuta Mizushima; Satoshi Katayanagi; Kazuhisa Matsumoto; Shigeru Toyoda; Teruo Inoue
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

6.  Short physical performance battery for middle-aged and older adult cardiovascular disease patients: implication for strength tests and lower extremity morphological evaluation.

Authors:  Tomohiro Yasuda; Kazuya Fukumura; Toshiaki Nakajima
Journal:  J Phys Ther Sci       Date:  2017-04-20

Review 7.  Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis.

Authors:  Joanna Saluk-Bijak; Angela Dziedzic; Michal Bijak
Journal:  Cells       Date:  2019-02-01       Impact factor: 6.600

Review 8.  Metformin as a Potential Agent in the Treatment of Multiple Sclerosis.

Authors:  Angela Dziedzic; Joanna Saluk-Bijak; Elzbieta Miller; Michal Bijak
Journal:  Int J Mol Sci       Date:  2020-08-19       Impact factor: 5.923

9.  Postural abnormality as a risk marker for leg deep venous thrombosis in Parkinson's disease.

Authors:  Kazushi Yamane; Fumiharu Kimura; Kiichi Unoda; Takafumi Hosokawa; Takahiko Hirose; Hiroki Tani; Yoshimitsu Doi; Simon Ishida; Hideto Nakajima; Toshiaki Hanafusa
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

10.  Anesthetic management of a patient with multiple sclerosis undergoing cesarean section with low dose epidural bupivacaine.

Authors:  Sameer Sethi; Sonia Kapil
Journal:  Saudi J Anaesth       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.